
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
HLA‐G expression is associated with metastasis and poor survival in the Balb/c nu/nu murine tumor model with ovarian cancer
Aifen Lin, Xia Zhang, Huihui Xu, et al.
International Journal of Cancer (2011) Vol. 131, Iss. 1, pp. 150-157
Closed Access | Times Cited: 41
Aifen Lin, Xia Zhang, Huihui Xu, et al.
International Journal of Cancer (2011) Vol. 131, Iss. 1, pp. 150-157
Closed Access | Times Cited: 41
Showing 1-25 of 41 citing articles:
HLA-G
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
Edgardo D. Carosella, Nathalie Rouas‐Freiss, Diana Tronik‐Le Roux, et al.
Advances in immunology (2015), pp. 33-144
Closed Access | Times Cited: 341
A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G
Edgardo D. Carosella, Guillaume Ploussard, Joël LeMaoult, et al.
European Urology (2015) Vol. 68, Iss. 2, pp. 267-279
Closed Access | Times Cited: 213
Edgardo D. Carosella, Guillaume Ploussard, Joël LeMaoult, et al.
European Urology (2015) Vol. 68, Iss. 2, pp. 267-279
Closed Access | Times Cited: 213
The immunosuppressive molecule HLA-G and its clinical implications
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
Álvaro González, Vera Rebmann, Joël LeMaoult, et al.
Critical Reviews in Clinical Laboratory Sciences (2012) Vol. 49, Iss. 3, pp. 63-84
Closed Access | Times Cited: 190
Unveiling the Peptide Motifs of HLA-C and HLA-G from Naturally Presented Peptides and Generation of Binding Prediction Matrices
Moreno Di Marco, Heiko Schuster, Linus Backert, et al.
The Journal of Immunology (2017) Vol. 199, Iss. 8, pp. 2639-2651
Open Access | Times Cited: 100
Moreno Di Marco, Heiko Schuster, Linus Backert, et al.
The Journal of Immunology (2017) Vol. 199, Iss. 8, pp. 2639-2651
Open Access | Times Cited: 100
Harnessing the immune system against cancer: current immunotherapy approaches and therapeutic targets
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8075-8095
Open Access | Times Cited: 88
Ayana R. Kumar, Aswathy R. Devan, Bhagyalakshmi Nair, et al.
Molecular Biology Reports (2021) Vol. 48, Iss. 12, pp. 8075-8095
Open Access | Times Cited: 88
Immunomodulatory Properties of HLA-G in Infectious Diseases
Laurence Amiot, Nicolas Vu, Michel Samson
Journal of Immunology Research (2014) Vol. 2014, pp. 1-14
Open Access | Times Cited: 89
Laurence Amiot, Nicolas Vu, Michel Samson
Journal of Immunology Research (2014) Vol. 2014, pp. 1-14
Open Access | Times Cited: 89
Prognostic value of HLA class I, HLA-E, HLA-G and Tregs in rectal cancer: a retrospective cohort study
Marlies S. Reimers, C.C. Engels, Hein Putter, et al.
BMC Cancer (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 81
Marlies S. Reimers, C.C. Engels, Hein Putter, et al.
BMC Cancer (2014) Vol. 14, Iss. 1
Open Access | Times Cited: 81
HLA-G: A New Immune Checkpoint in Cancer?
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4528-4528
Open Access | Times Cited: 66
Daniëlle Krijgsman, Jessica Roelands, Wouter Hendrickx, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4528-4528
Open Access | Times Cited: 66
HLA-G Neo-Expression on Tumors
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
Maria Loustau, François Anna, Raphaelle Dréan, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 58
In vivo evidence that secretion of HLA‐G by immunogenic tumor cells allows their evasion from immunosurveillance
Laure Loumagne, Jérémy Baudhuin, Benoı̂t Favier, et al.
International Journal of Cancer (2014) Vol. 135, Iss. 9, pp. 2107-2117
Open Access | Times Cited: 66
Laure Loumagne, Jérémy Baudhuin, Benoı̂t Favier, et al.
International Journal of Cancer (2014) Vol. 135, Iss. 9, pp. 2107-2117
Open Access | Times Cited: 66
Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression
Xiang-Juan Li, Xia Zhang, Aifen Lin, et al.
Human Immunology (2012) Vol. 73, Iss. 9, pp. 946-949
Closed Access | Times Cited: 66
Xiang-Juan Li, Xia Zhang, Aifen Lin, et al.
Human Immunology (2012) Vol. 73, Iss. 9, pp. 946-949
Closed Access | Times Cited: 66
Multiple steps of HLA-G in ovarian carcinoma metastasis: Alter NK cytotoxicity and induce matrix metalloproteinase-15 (MMP-15) expression
Aifen Lin, Huihui Xu, Dan‐Ping Xu, et al.
Human Immunology (2012) Vol. 74, Iss. 4, pp. 439-446
Closed Access | Times Cited: 49
Aifen Lin, Huihui Xu, Dan‐Ping Xu, et al.
Human Immunology (2012) Vol. 74, Iss. 4, pp. 439-446
Closed Access | Times Cited: 49
Clinical implication of human leukocyte antigen ( HLA )‐ F expression in breast cancer
Aya Harada, Sumiya Ishigami, Yuko Kijima, et al.
Pathology International (2015) Vol. 65, Iss. 11, pp. 569-574
Open Access | Times Cited: 41
Aya Harada, Sumiya Ishigami, Yuko Kijima, et al.
Pathology International (2015) Vol. 65, Iss. 11, pp. 569-574
Open Access | Times Cited: 41
The role of immune checkpoints in antitumor response: a potential antitumor immunotherapy
Lidy Vannessa Mejía-Guarnizo, Paula Stefany Monroy-Camacho, Andrés David Turizo-Smith, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Lidy Vannessa Mejía-Guarnizo, Paula Stefany Monroy-Camacho, Andrés David Turizo-Smith, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
NK cytolysis is dependent on the proportion of HLA-G expression
Baoguo Chen, Dan‐Ping Xu, Aifen Lin, et al.
Human Immunology (2012) Vol. 74, Iss. 3, pp. 286-289
Closed Access | Times Cited: 38
Baoguo Chen, Dan‐Ping Xu, Aifen Lin, et al.
Human Immunology (2012) Vol. 74, Iss. 3, pp. 286-289
Closed Access | Times Cited: 38
High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β
Matti Ullah, Dallel Azazzen, Rachid Kaci, et al.
Neoplasia (2019) Vol. 21, Iss. 3, pp. 331-342
Open Access | Times Cited: 26
Matti Ullah, Dallel Azazzen, Rachid Kaci, et al.
Neoplasia (2019) Vol. 21, Iss. 3, pp. 331-342
Open Access | Times Cited: 26
Clinicopathologic significance of HLA-G and HLA-E molecules in Tunisian patients with ovarian carcinoma
Wafa Babay, Hamza Ben Yahia, Nadia Boujelbène, et al.
Human Immunology (2018) Vol. 79, Iss. 6, pp. 463-470
Closed Access | Times Cited: 26
Wafa Babay, Hamza Ben Yahia, Nadia Boujelbène, et al.
Human Immunology (2018) Vol. 79, Iss. 6, pp. 463-470
Closed Access | Times Cited: 26
Possible roles of HLA-G regulating immune cells in pregnancy and endometrial diseases via KIR2DL4
Yixuan Bai, Junhui Liang, Wei Liu, et al.
Journal of Reproductive Immunology (2020) Vol. 142, pp. 103176-103176
Closed Access | Times Cited: 21
Yixuan Bai, Junhui Liang, Wei Liu, et al.
Journal of Reproductive Immunology (2020) Vol. 142, pp. 103176-103176
Closed Access | Times Cited: 21
HLA-G1 and HLA-G5 isoforms have an additive effect on NK cytolysis
Weiqun Zhang, Dan‐Ping Xu, Di Liu, et al.
Human Immunology (2013) Vol. 75, Iss. 2, pp. 182-189
Closed Access | Times Cited: 25
Weiqun Zhang, Dan‐Ping Xu, Di Liu, et al.
Human Immunology (2013) Vol. 75, Iss. 2, pp. 182-189
Closed Access | Times Cited: 25
Checkpoint Inhibitors in Bladder and Renal Cancers: Results and Perspectives
Fouad Aoun, Hampig Raphaël Kourié, Spyridon Sideris, et al.
Immunotherapy (2015) Vol. 7, Iss. 12, pp. 1259-1271
Closed Access | Times Cited: 23
Fouad Aoun, Hampig Raphaël Kourié, Spyridon Sideris, et al.
Immunotherapy (2015) Vol. 7, Iss. 12, pp. 1259-1271
Closed Access | Times Cited: 23
Clinical Significance of Potential Unidentified HLA-G Isoforms Without α1 Domain but Containing Intron 4 in Colorectal Cancer Patients
Aifen Lin, Xia Zhang, Ruili Zhang, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 23
Aifen Lin, Xia Zhang, Ruili Zhang, et al.
Frontiers in Oncology (2018) Vol. 8
Open Access | Times Cited: 23
HLA-G/sHLA-G and HLA-G-Bearing Extracellular Vesicles in Cancers: Potential Role as Biomarkers
Peilong Li, Nan Wang, Yi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Peilong Li, Nan Wang, Yi Zhang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 16
Lesion HLA-G5/-G6 isoforms expression in patients with ovarian cancer
Xia Zhang, Qiu-Yue Han, Jingbo Li, et al.
Human Immunology (2015) Vol. 77, Iss. 9, pp. 780-784
Closed Access | Times Cited: 17
Xia Zhang, Qiu-Yue Han, Jingbo Li, et al.
Human Immunology (2015) Vol. 77, Iss. 9, pp. 780-784
Closed Access | Times Cited: 17
An HLA-G/SPAG9/STAT3 axis promotes brain metastases
Blessing Bassey‐Archibong, Chirayu Chokshi, Nikoo Aghaei, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 8
Open Access | Times Cited: 5
Blessing Bassey‐Archibong, Chirayu Chokshi, Nikoo Aghaei, et al.
Proceedings of the National Academy of Sciences (2023) Vol. 120, Iss. 8
Open Access | Times Cited: 5
Inhibition of host immune response in colorectal cancer: Human leukocyte antigen-G and beyond
Marica Garziera
World Journal of Gastroenterology (2014) Vol. 20, Iss. 14, pp. 3778-3778
Open Access | Times Cited: 14
Marica Garziera
World Journal of Gastroenterology (2014) Vol. 20, Iss. 14, pp. 3778-3778
Open Access | Times Cited: 14